Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $13,411 | 3 | 38.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,715 | 3 | 30.7% |
| Travel and Lodging | $5,131 | 11 | 14.7% |
| Grant | $4,691 | 1 | 13.4% |
| Food and Beverage | $960.50 | 34 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $34,548 | 29 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $101.95 | 6 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $38.32 | 3 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $30.86 | 2 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $21.24 | 1 | $0 (2020) |
| Allergan Inc. | $21.16 | 1 | $0 (2019) |
| Mallinckrodt LLC | $17.51 | 1 | $0 (2018) |
| UCB, Inc. | $17.50 | 1 | $0 (2017) |
| Antares Pharma, Inc. | $17.44 | 1 | $0 (2019) |
| Lundbeck LLC | $15.96 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14.63 | 1 | Neurocrine Biosciences, Inc. ($14.63) |
| 2022 | $20.60 | 1 | AstraZeneca Pharmaceuticals LP ($20.60) |
| 2021 | $19.06 | 1 | AstraZeneca Pharmaceuticals LP ($19.06) |
| 2020 | $94.91 | 6 | AstraZeneca Pharmaceuticals LP ($62.29) |
| 2019 | $13,118 | 15 | Novartis Pharmaceuticals Corporation ($13,023) |
| 2018 | $19,365 | 15 | Novartis Pharmaceuticals Corporation ($19,332) |
| 2017 | $2,275 | 13 | Novartis Pharmaceuticals Corporation ($2,193) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Neuropsychiatry | ||||||
| 06/16/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Respiratory | ||||||
| 02/23/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Respiratory | ||||||
| 10/20/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Respiratory | ||||||
| 09/30/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Respiratory | ||||||
| 09/19/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/01/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Respiratory | ||||||
| 02/27/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Respiratory | ||||||
| 01/31/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.38 | General |
| Category: Cardiovascular | ||||||
| 12/07/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Consulting Fee | Cash or cash equivalent | $7,516.50 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Travel and Lodging | Cash or cash equivalent | $415.25 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Travel and Lodging | In-kind items and services | $404.54 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $85.06 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2019 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $3,947.00 | General |
| 12/05/2019 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | Cash or cash equivalent | $340.94 | General |
| 12/05/2019 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $240.25 | General |
| 12/05/2019 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $59.50 | General |
| 07/31/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/12/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.48 | General |
| Category: Cardiovascular | ||||||
| 07/03/2019 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| 07/01/2019 | United Therapeutics Corporation | ORENITRAM (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: PAH | ||||||
| 04/16/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.46 | General |
| Category: Cardiovascular | ||||||
| 03/19/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/21/2018 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $1,947.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 332 | 611 | $84,570 | $39,828 |
| 2022 | 10 | 353 | 613 | $83,097 | $43,677 |
| 2021 | 13 | 605 | 968 | $106,756 | $57,268 |
| 2020 | 17 | 678 | 1,035 | $103,370 | $48,922 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 132 | 357 | $62,475 | $28,603 | 45.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 42 | 42 | $8,526 | $5,146 | 60.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 45 | $5,625 | $2,534 | 45.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 23 | 23 | $1,541 | $1,510 | 98.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 20 | 21 | $1,365 | $703.69 | 51.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 23 | 23 | $1,012 | $675.28 | 66.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 33 | $1,716 | $328.91 | 19.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 19 | 22 | $1,584 | $196.20 | 12.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 11 | 11 | $440.00 | $97.54 | 22.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 11 | 34 | $285.59 | $32.81 | 11.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 122 | 311 | $51,275 | $25,810 | 50.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 67 | 67 | $13,601 | $8,594 | 63.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 46 | $5,572 | $3,035 | 54.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 13 | $4,199 | $2,037 | 48.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 25 | 25 | $1,675 | $1,640 | 97.9% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 25 | 29 | $1,885 | $1,237 | 65.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 26 | 27 | $1,188 | $756.64 | 63.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 13 | 41 | $2,132 | $377.11 | 17.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 14 | 16 | $1,152 | $145.38 | 12.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 12 | 38 | $418.00 | $44.54 | 10.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 116 | 331 | $50,245 | $27,562 | 54.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 53 | 53 | $8,162 | $6,917 | 84.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 32 | 41 | $12,315 | $6,513 | 52.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 24 | 76 | $8,740 | $4,346 | 49.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 17 | 39 | $6,410 | $3,204 | 50.0% |
About Dr. Mohammed Khan, MD
Dr. Mohammed Khan, MD is a Internal Medicine healthcare provider based in Westlake, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891765186.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammed Khan, MD has received a total of $34,908 in payments from pharmaceutical and medical device companies, with $14.63 received in 2024. These payments were reported across 52 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($13,411).
As a Medicare-enrolled provider, Khan has provided services to 1,968 Medicare beneficiaries, totaling 3,227 services with total Medicare billing of $189,695. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Westlake, OH
- Active Since 01/26/2006
- Last Updated 01/12/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1891765186
Products in Payments
- COSENTYX (Biological) $8,821
- FASENRA (Drug) $62.29
- FASENRA (Biological) $39.66
- ELIQUIS (Drug) $38.32
- ENTRESTO (Drug) $21.98
- DUPIXENT (Biological) $21.24
- VRAYLAR (Drug) $21.16
- PRADAXA (Drug) $19.29
- ACTHAR (Biological) $17.51
- Vimpat (Drug) $17.50
- XYOSTED (Drug) $17.44
- NORTHERA (Drug) $15.96
- INVOKANA (Drug) $15.23
- INGREZZA (Drug) $14.63
- ORENITRAM (Drug) $14.47
- Prolia (Biological) $12.23
- SPIRIVA (Drug) $11.57
- TOUJEO (Drug) $10.77
- Victoza (Drug) $10.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Westlake
Naim Alkhouri, Md, MD
Internal Medicine — Payments: $1.5M
John Coletta, M.d, M.D
Internal Medicine — Payments: $199,959
Arash Rashidi, M.d, M.D
Internal Medicine — Payments: $115,043
Antonios Paras, Md, MD
Internal Medicine — Payments: $10,972
Buthayna Dinary, M.d, M.D
Internal Medicine — Payments: $6,482
Niculina Olariu, Md, MD
Internal Medicine — Payments: $4,211